| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMJCARD.2007.04.029 |
| P8608 | Fatcat ID | release_ab3g3vzq3fhwzmec4qlta6xg2u |
| P698 | PubMed publication ID | 17826372 |
| P5875 | ResearchGate publication ID | 6014846 |
| P50 | author | Don Poldermans | Q2465287 |
| Eike Nagel | Q45907623 | ||
| Eric Boersma | Q57288054 | ||
| Jeroen Joost Bax | Q77085900 | ||
| Hildo J Lamb | Q85434264 | ||
| Sebastian Kelle | Q92146603 | ||
| Albert de Roos | Q92308263 | ||
| Ernst E. van der Wall | Q112536033 | ||
| Eckart Fleck | Q114312373 | ||
| Theodorus A M Kaandorp | Q114403027 | ||
| P2093 | author name string | Stijntje D Roes | |
| Thomas Kokocinski | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 930-936 | |
| P577 | publication date | 2007-07-05 | |
| P1433 | published in | American Journal of Cardiology | Q2208417 |
| P1476 | title | Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction | |
| P478 | volume | 100 |
| Q30363490 | Advanced echocardiographic techniques. |
| Q30434105 | Advances in Cardiovascular MRI for Diagnostics: Applications in Coronary Artery Disease and Cardiomyopathies |
| Q38081156 | Assessing myocardial recovery following ST-segment elevation myocardial infarction: short- and long-term perspectives using cardiovascular magnetic resonance |
| Q35221999 | Assessment of myocardial infarction by cardiac magnetic resonance imaging and long-term mortality |
| Q34417974 | Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging |
| Q37240733 | Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post-Reperfused ST-Elevation Myocardial Infarction |
| Q38221422 | Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells |
| Q47191457 | C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction |
| Q55537860 | CMRSegTools: an Osirix plugin for myocardial infarct sizing on DE-CMR images. |
| Q57665132 | CSI position statement on management of heart failure in India |
| Q26786658 | Cardiac MR imaging: current status and future direction |
| Q38263089 | Cardiac MRI: a central prognostic tool in myocardial fibrosis |
| Q90407015 | Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling |
| Q35238181 | Cardiac magnetic resonance imaging analysis in STEMI: quantitative or still visual? |
| Q35124348 | Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpoints |
| Q38018564 | Cardiovascular magnetic resonance imaging in ischemic heart disease |
| Q30480182 | Clinical applications for cardiovascular magnetic resonance imaging at 3 tesla |
| Q52876944 | Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA. |
| Q37074696 | Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability |
| Q38973259 | Diffusion Tensor Imaging of Healthy and Infarcted Porcine Hearts: Study on the Impact of Formalin Fixation |
| Q36946837 | Dobutamine stress cardiovascular magnetic resonance at 3 Tesla |
| Q50616853 | Early systolic lengthening may identify minimal myocardial damage in patients with non-ST-elevation acute coronary syndrome. |
| Q58608787 | Ectopic beats arise from micro-reentries near infarct regions in simulations of a patient-specific heart model |
| Q38126089 | Emerging concepts for myocardial late gadolinium enhancement MRI. |
| Q27002606 | Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel |
| Q82623487 | Epicardium and pericardium: a joint force for infarct repair? |
| Q47270854 | Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study |
| Q91589952 | Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients - data from the CHILL-MI, MITOCARE and SOCCER trials |
| Q82992456 | Head to head comparison of quantitative versus visual analysis of contrast CMR in the setting of myocardial stunning after STEMI: implications on late systolic function and patient outcome |
| Q26824350 | Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance |
| Q37521985 | Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance. |
| Q46744931 | Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction |
| Q83403984 | Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers |
| Q38206843 | Individualized cardiovascular risk assessment by cardiovascular magnetic resonance |
| Q36237173 | Infarct healing is a dynamic process following acute myocardial infarction. |
| Q84153015 | Infarct tissue characteristics of patients with versus without early revascularization for acute myocardial infarction: a contrast-enhancement cardiovascular magnetic resonance imaging study |
| Q36549998 | Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging. |
| Q90668327 | Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization |
| Q36118129 | Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease. |
| Q38683717 | MRI in the assessment of ischaemic heart disease. |
| Q38736889 | Magnetic resonance imaging for characterizing myocardial diseases |
| Q38100155 | Magnetic resonance imaging in the evaluation of congestive cardiac failure |
| Q54988407 | Noninvasive Evaluation of Symptomatic Women with Suspected Coronary Artery Disease. |
| Q28085424 | Physiological Implications of Myocardial Scar Structure |
| Q26849357 | Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI |
| Q50951499 | Prediction of left ventricular contractile recovery using tissue Doppler strain and strain rate measurements at rest in patients undergoing percutaneous coronary intervention. |
| Q53277125 | Prediction of long-term reverse left ventricular remodeling after revascularization or medical treatment in patients with ischemic cardiomyopathy: a comparative study between SPECT and MRI. |
| Q35763929 | Predictors of acute myocardial infarct size in STEMI patients receiving thrombolytic therapy: A delayed contrast enhanced cardiac MRI study |
| Q37945796 | Principles, current status and clinical implications of ischaemic heart disease assessment by cardiac magnetic resonance imaging |
| Q24653881 | Protective modulation of carotid atherosclerosis in hyperalphalipoproteinemic individuals |
| Q37670689 | Quantification in cardiac MRI: advances in image acquisition and processing |
| Q35084600 | Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial |
| Q57448705 | Reliability of myocardial salvage assessment by cardiac magnetic resonance imaging in acute reperfused myocardial infarction |
| Q41127363 | Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging |
| Q40052697 | Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging |
| Q37980258 | Role of cardiac magnetic resonance imaging in assessing ischemic and nonischemic cardiomyopathies |
| Q54548935 | Role of left ventricular dyssynchrony in predicting remodeling after ST elevation myocardial infarction. |
| Q37090723 | Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint |
| Q93083129 | Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS |
| Q38968954 | T(Rho) and magnetization transfer and INvErsion recovery (TRAMINER)-prepared imaging: A novel contrast-enhanced flow-independent dark-blood technique for the evaluation of myocardial late gadolinium enhancement in patients with myocardial infarction |
| Q37738593 | Taxonomy of segmental myocardial systolic dysfunction |
| Q27014679 | The cardiac magnetic resonance (CMR) approach to assessing myocardial viability |
| Q38777735 | The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality. |
| Q88723657 | The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts |
| Q47394429 | The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study |
| Q28247457 | The stuttering progress of cell therapy for heart disease |
| Q92638131 | Time-Dependent Myocardial Necrosis in Patients With ST-Segment-Elevation Myocardial Infarction Without Angiographic Collateral Flow Visualized by Cardiac Magnetic Resonance Imaging: Results From the Multicenter STEMI-SCAR Project |
| Q64062178 | Use of Multifactorial Treatments to Address the Challenge of Translating Experimental Myocardial Infarct Reduction Strategies |
| Q37314823 | Use of cardiovascular magnetic resonance imaging in acute coronary syndromes |
| Q36225152 | Value of C-reactive protein in predicting left ventricular remodelling in patients with a first ST-segment elevation myocardial infarction |
| Q43132074 | Viability assessment with MRI is superior to FDG-PET for viability: Pro. |
| Q52888555 | Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients. |
| Q51940406 | [Update on cardiac imaging techniques: echocardiography, cardiac magnetic resonance, and multidetector computed tomography]. |
Search more.